Chlorophyllipt^® (Tablets, Solution) Instructions for Use

ATC Code

D06BX (Other chemotherapeutic preparations for topical use)

Active Substance

Eucalypti folium (DAB German Pharmacopoeia)

Clinical-Pharmacological Group

Herbal preparation with antimicrobial action

Pharmacotherapeutic Group

Antimicrobial agent of plant origin

Pharmacological Action

A preparation of plant origin. Aqueous and alcoholic extracts from eucalyptus leaves exhibit bactericidal, antiviral, fungicidal, antiprotozoal, and anti-inflammatory effects. The degree of their severity depends on the content of essential oil (0.3-4.5%).

The activity of the main component of the essential oil, cineole (65-85%), is potentiated by pinenes, myrtenol, and tannins (up to 6%). When taken orally and in inhalations, eucalyptus preparations cause expectorant, mucolytic, and bronchodilator effects, and when applied to the skin – astringent, anti-exudative, antipruritic, anesthetic, and in higher concentrations, local irritant action. The infusion of eucalyptus leaves, due to the essential oil and a small amount of bitters, increases the secretion of the digestive glands and improves digestion. When used in the form of a tincture, a sedative effect is manifested, due to the aldehyde of isovaleric acid.

Chlorophyllipt^®, containing a mixture of chlorophylls from eucalyptus leaves, possesses antimicrobial, particularly antistaphylococcal, activity and stimulates regeneration processes. The components of the essential oil, together with organic acids, tannins, and trace elements manganese, zinc, and selenium, increase tissue resistance to hypoxia of various origins.

Indications

As part of combination therapy for acute and chronic infectious and inflammatory diseases of various localization: rhinitis, stomatitis, gingivitis, laryngitis, bronchitis, pneumonia, hyposecretory gastritis, enterocolitis, dysbacteriosis, cholecystitis, pyelonephritis, vaginitis, colpitis, cervical erosion, burns, dermatitis, radiculitis, neuritis, myositis, trophic ulcers, neurosis, mild form of insomnia, osteochondrosis.

ICD codes

Dosage Regimen

Administer orally, topically, externally, by inhalation, or via intracavitary routes based on the specific clinical indication and the pharmaceutical form utilized.

For oral administration of tablets, adhere to the specific product information; typically, use one tablet for oromucosal dissolution several times daily.

For gargling, dilute a 1% alcoholic solution: use 5 ml (approximately one teaspoon) in 30 ml of water.

For intracavitary administration, such as vaginal irrigation or cervical treatment, dilute a 1% solution: use 15 ml in one liter of water.

For enemas, dilute a 1% solution: use 20 ml in one liter of water.

For inhalation therapy, dilute a 1% alcoholic solution: use 1 ml per 10 ml of physiological sodium chloride solution.

For external application on wounds, ulcers, or burns, apply a 2% oil-based solution directly to the affected area.

For internal use of the solution, dilute 5 ml (one teaspoon) of a 1% alcoholic solution in 30 ml of water; administer this three times daily.

Adjust the dose, frequency, and treatment duration individually according to the diagnosed condition, severity, and patient age.

Before initiating a full course, mandatorily perform a sensitivity test by administering 25 drops of a 1% alcoholic solution in one tablespoon of water; observe for 6-8 hours for any allergic manifestations.

Adverse Reactions

Possible allergic reactions to the components of the essential oil and chlorophyllipt; when taken orally in high doses – nausea, vomiting, diarrhea, muscle spasms; with frequent and/or prolonged inhalation use – dryness of the mucous membranes of the respiratory tract.

Contraindications

Hypersensitivity to the components of the essential oil and chlorophyllipt; atrophy of the mucous membranes of the upper respiratory tract.

Use in Pregnancy and Lactation

The use of eucalyptus leaf preparations containing ethyl alcohol is contraindicated during pregnancy and breastfeeding.

Pediatric Use

The use of eucalyptus leaf preparations containing ethyl alcohol is contraindicated in children and adolescents under 18 years of age.

Special Precautions

Use with caution in cases of increased secretion of the digestive glands.

Avoid contact of eucalyptus preparations (especially tincture, eucalyptus oil, chlorophyllipt) with the eyes.

Before starting treatment, it is necessary to check the patient’s sensitivity to the plant. For this, the patient is given a tablespoon of infusion, 10 drops of tincture, or 25 drops of a 1% alcoholic solution of chlorophyllipt in 1 tablespoon of water to drink. If no allergic reactions occur within 6-8 hours, a course of treatment can be prescribed. A negative attitude of the patient towards the smell of eucalyptus may indicate intolerance.

Storage Conditions

Store at 2°C (36°F) to 25°C (77°F). Keep in original packaging, protected from light. Keep out of reach of children.

Dispensing Status

Over-the-Counter

Important Safety Information

This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.